Psyence Biomedical Ltd. Common Shares (PBM)
PBM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.55
-4.01% on the day
Market cap
$24.2M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | PBM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001985062 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A6 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | F-3 | 2026-08-26 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-06-22 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-05 |
Source: SEC EDGAR submissions feed, 168 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| PBMWW | Psyence Biomedical Ltd. Warrant | $0.0152 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $2.89 | +2.48% | $24.5M |
| KYNB | Kyntra Bio Inc. | $5.87 | -4.08% | $23.8M |
| SHPH | Shuttle Pharmaceuticals Holdings Inc. | $5.18 | -4.95% | $24.7M |
| BYSI | BeyondSpring Inc. | $0.6067 | -1.43% | $24.9M |
| CNTX | Context Therapeutics Inc. | $0.2750 | -9.84% | $25.3M |
| MCRB | Seres Therapeutics Inc. | $2.53 | -5.60% | $25.4M |
| ATOS | Atossa Therapeutics Inc. | $2.56 | +7.17% | $25.5M |
| TXMD | TherapeuticsMD Inc. | $1.96 | -2.97% | $22.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier